Valuations for share-based compensation are crucial for tax and financial reporting purposes. Our team of professionals is adept at performing these valuations.
We specialise in valuing a wide range of financial instruments, including preferred and common stock, options/warrants, performance options, growth shares, and convertible notes.
For acquisitions or mergers, we perform PPAs (Purchase Price Allocations) under IFRS 3 and FRS 102 Section 19, using best practices to provide robust valuations that withstand audit scrutiny.
Under IAS 36, we conduct annual or as-needed impairment testing for goodwill and indefinite life intangible assets, delivering defensible analyses for your business.
We provide well-documented and defensible valuations for illiquid portfolios, adhering to the IPEV (International Private Equity and Venture Capital Valuation) Guidelines.
IFRS 16, introduced in 2019, affects companies with leases that report under the IFRS (International Financial Reporting Standards). Our specialists determine specific IBRs for leases under IFRS 16, ensuring accurate financial reporting.